We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Entelos Regs | LSE:ENTL | London | Ordinary Share | COM SHS USD0.001 (REG S) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
Entelos, Inc. (LSE: ENTL) today is updating the market in advance of its year-end period ending 31 December 2008.
The current economic crisis has impacted almost every industry including our customer segment. Many of our
pharmaceutical customers have recently announced delays in some of their internal drug development programs. As a
result, the Company expects its fourth quarter revenues, and therefore full year revenues, to be below expectations. The
Company has made progress towards cash flow breakeven as cash receipts will be higher in the second half of 2008
compared to the first half of the year thus reducing the Company's burn rate.
The Company plans to report its full-year financial results in March 2009.
Enquiries
Entelos, Inc.
Alan Blazei, Chief Financial Officer Tel: +1 650 572 5400
Jill Fujisaki, Vice President, Investor Relations
KBC Peel Hunt, Ltd (Nominated Advisor and Broker)
Capel Irwin/David Anderson Tel: +44 (0) 20 4718 8900
Buchanan Communications
Lisa Baderoon/Mary-Jane Johnson Tel: +44 (0)20 7466 5000
About Entelos, Inc.
Entelos, Inc. ( www.entelos.com) is a US-based life sciences company applying next-generation predictive
technologies to revolutionize the way medicines are discovered, developed, and utilized. The Company leverages its
proprietary in silico disease models, "virtual human" technology, and toxicology reference systems to develop safer and
more effective drugs, improve the quality of health-related consumer products, and deliver on the promise of
personalized medicine. Entelos provides customized products, technology and research services to global pharmaceutical,
health-care, and consumer products companies in safety testing, arthritis, cardiovascular diseases, asthma, obesity,
diabetes, hematopoeisis (anemia), cholesterol metabolism, skin sensitization, and personal care products.
1 Year Entelos Regs Chart |
1 Month Entelos Regs Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
